Richard Ressler - CREMETRSBI DL-001 Chairman of the Board

WY52 Stock  EUR 1.70  0.00  0.00%   

Insider

Richard Ressler is Chairman of the Board of CREMECOMTRSBI DL 001 since 2014.
Age 60
Tenure 11 years
Phone972-349-3200
Webhttp://www.cimcommercial.com

Richard Ressler Latest Insider Activity

Tracking and analyzing the buying and selling activities of Richard Ressler against CREMETRSBI DL-001 stock is an integral part of due diligence when investing in CREMETRSBI DL-001. Richard Ressler insider activity provides valuable insight into whether CREMETRSBI DL-001 is net buyers or sellers over its current business cycle. Note, CREMETRSBI DL-001 insiders must abide by specific rules, including filing SEC forms every time they buy or sell CREMETRSBI DL-001'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

CREMETRSBI DL-001 Management Efficiency

The company has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMETRSBI DL-001's management efficiency ratios could be used to measure how well CREMETRSBI DL-001 manages its routine affairs as well as how well it operates its assets and liabilities.
CREMECOMTRSBI DL 001 has accumulated 260.72 M in total debt with debt to equity ratio (D/E) of 0.64, which is about average as compared to similar companies. CREMECOMTRSBI DL 001 has a current ratio of 7.13, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CREMETRSBI DL-001 until it has trouble settling it off, either with new capital or with free cash flow. So, CREMETRSBI DL-001's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CREMECOMTRSBI DL 001 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CREMETRSBI to invest in growth at high rates of return. When we think about CREMETRSBI DL-001's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Charles CannadaCOUSINS PTIES INC
60
Douglas LindeBoston Properties
59
Bryan KoopBoston Properties
64
Michael LaBelleBoston Properties
59
Laura SesodyBoston Properties
N/A
Christopher BilottoOffice Properties Income
45
BA MAGreat Portland Estates
N/A
Anisha BAGreat Portland Estates
N/A
Dan MAGreat Portland Estates
N/A
Scott FordhamCOUSINS PTIES INC
51
Matthew BrownOffice Properties Income
41
Kevin BarryOffice Properties Income
N/A
Jennifer ClarkOffice Properties Income
62
MA MAGreat Portland Estates
54
Eric KevorkianBoston Properties
N/A
Donna HylandCOUSINS PTIES INC
58
Olivia SnyderOffice Properties Income
N/A
Darren LLBGreat Portland Estates
N/A
MIOSH AIEMAGreat Portland Estates
N/A
Jeffrey SymesCOUSINS PTIES INC
53
Richard HicksonCOUSINS PTIES INC
44
CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people. CREMECOMTRSBI DL 001 (WY52) is traded on Frankfurt Exchange in Germany and employs 5 people.

Management Performance

CREMECOMTRSBI DL 001 Leadership Team

Elected by the shareholders, the CREMETRSBI DL-001's board of directors comprises two types of representatives: CREMETRSBI DL-001 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMETRSBI. The board's role is to monitor CREMETRSBI DL-001's management team and ensure that shareholders' interests are well served. CREMETRSBI DL-001's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMETRSBI DL-001's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Salit, President Secretary
Frank Golay, Independent Director
Avi Shemesh, Director
Avraham Shemesh, Director
David Thompson, Chief Executive Officer
Robert Cresci, Independent Director
Kelly Eppich, Independent Director
Douglas Bech, Independent Director
Richard Ressler, Chairman of the Board
Shaul Kuba, Director
Nathan DeBacker, Chief Financial Officer

CREMETRSBI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMETRSBI DL-001 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in CREMETRSBI Stock

CREMETRSBI DL-001 financial ratios help investors to determine whether CREMETRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMETRSBI with respect to the benefits of owning CREMETRSBI DL-001 security.